THE WIRE Β· β 66496
π¨πΊπΈ New York just declared a STATEWIDE EMERGENCY DIASTER over measles Hochul's order lets paramedics, midwives and pharmacists give MMR shots, and pharmacists can now vaccinate kids as young as 2, after 108 New Yorkers caught measles this year, most of them in rural counties alo
01 THE MACHINE READ
WHY IT MATTERS.
Measles outbreak emergency affects public-health policy but has minimal direct market transmission.
Public-health emergency with limited market read
Case counts and policy response
Localized, low market relevance
FULL DISPATCH
π¨πΊπΈ New York just declared a STATEWIDE EMERGENCY DIASTER over measles Hochul's order lets paramedics, midwives and pharmacists give MMR shots, and pharmacists can now vaccinate kids as young as 2, after 108 New Yorkers caught measles this year, most of them in rural counties along the Pennsylvania line. That's because next door, Pennsylvania has hit 1,004 cases and 198 hospitalizations, the worst state outbreak in over 30 years, and all 5 people who died there were unvaccinated. America declared measles eliminated in 2000, yet the country is back at 3,887 cases. Which reminds me... over in Siberia, a lab worker died of PLAGUE after breaking a test tube, and about 200 people are now in isolation. Russia dusting off the plague while America dusts off measles is how you know 2026 is cleaning out the attic before the year endsπ Source: NYT, Reuters / Writer: Daniel, Sol
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM β NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
GE HealthCare is expected to announce Monday a $945 million cash purchase of a manufacturer of radioactive substances used in medical imaging procedures like PET scans2026-10-05 11:32 UTC
Pharmalittle: We're reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more2026-10-05 18:01 UTC
Pharma firms closed biopharma buyouts worth over a hundred billion dollars in the first half of the year, racing to replace top selling medicines worth around $400 billion before patents expire. Leah Bennett of Concurrent explains2026-10-05 20:15 UTC
AstraZeneca CEO says Summit drug could drive next generation of cancer combinations2026-10-05 20:30 UTC
Option Care Health surges 22% on report of $5 billion takeover by McKesson, CD&R2026-10-05 20:44 UTC
LYCA IPO News - Lycia Therapeutics files for a $100 million IPO, targeting food allergies and autoimmune diseases2026-10-05 21:41 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors β every claim links its sources.